LDL receptors on cell membrane

Infographic: PEGylated lipid nanoparticles (LNPs)

PEGylated lipid nanoparticles (LNPs) are used to keep therapeutics hidden from the immune system. How successful are they, and what happens if they are caught?

Learn more in the infographic below and subscribe to stay ahead of emerging trends in science.

For more on this topic, check out the CAS Insights article, “The ultimate guide for PEGylated lipid nanoparticles,”  and our in-depth, peer-reviewed journal publication in Bioconjugate Chemistry.

PEGylated LNPs are used to successfully deliver cancer therapeutics Nearly two-thirds of the PEGylated LNP formulations are developed for transporting anti-tumor agents (64.5%).
Download the infographicDownload the infographic

Related CAS Insights

Emerging Science

16 billion reasons for hope: How biomarkers are reshaping cancer outcomes

March 20, 2024

Read article
Emerging Science

Advancing progress in the fight against fentanyl

May 9, 2023

Read article
Emerging Science

Aging reimagined: Exploring the potential of anti-aging treatment strategies

July 21, 2023

Read article

Gain new perspectives for faster progress directly to your inbox.